scholarly article | Q13442814 |
P50 | author | Stephen D. Luzio | Q43227308 |
Gareth J Dunseath | Q56868243 | ||
P2093 | author name string | David R Owens | |
Paul M Underwood | |||
Lawrence S Cozma | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P304 | page(s) | 1001-1007 | |
P577 | publication date | 2005-05-01 | |
P1433 | published in | Diabetes Care | Q5270111 |
P1476 | title | Beta-cell response during a meal test: a comparative study of incremental doses of repaglinide in type 2 diabetic patients | |
P478 | volume | 28 |
Q33709590 | A review of treatment response in type 2 diabetes: assessing the role of patient heterogeneity |
Q26829445 | Assessment of pancreatic β-cell function: review of methods and clinical applications |
Q37416127 | Combining insulin with metformin or an insulin secretagogue in non-obese patients with type 2 diabetes: 12 month, randomised, double blind trial. |
Q57951374 | Comparison of daytime 12-hour metabolic profiles after treatment with repaglinide and gliclazide in type 2 diabetes |
Q45402322 | High molecular weight form of adiponectin levels of Japanese patients with chronic hepatitis C virus infection |
Q37223610 | Indices of insulin sensitivity and secretion from a standard liquid meal test in subjects with type 2 diabetes, impaired or normal fasting glucose |
Q28242989 | Meglitinide analogues: a review of clinical data focused on recent trials |
Q37977979 | Repaglinide: a review of its use in type 2 diabetes mellitus |
Q42873700 | Repeatability of Indices of Insulin Sensitivity and Secretion from Standard Liquid Meal Tests in Subjects with Type 2 Diabetes Mellitus or Normal or Impaired Fasting Glucose |
Q53080005 | Treatment of young patients with HNF1A mutations (HNF1A-MODY). |
Search more.